Lemaitre Vascular (LMAT) Asset Writedowns and Impairment (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Asset Writedowns and Impairment data on file, last reported at $761000.0 in Q1 2026.

• Asset Writedowns and Impairment for Q1 2026 came in at $761000.0, up 6241.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (up 42.8% YoY), and the FY2025 annual result was $2.7 million, down 13.94% from the prior year.
• Asset Writedowns and Impairment retreated to $761000.0 in Q1 2026 per LMAT's latest filing, from $768000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $2.6 million in Q4 2024 and troughed at -$764000.0 in Q3 2024.
• A 5-year average of $666058.8 and a median of $544000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2024 and 2026: Asset Writedowns and Impairment slumped 978.16% in 2024, then soared 6241.67% in 2026.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $512000.0 in 2022, then surged by 325.2% to $2.2 million in 2023, then climbed by 19.25% to $2.6 million in 2024, then sank by 70.42% to $768000.0 in 2025, then decreased by 0.91% to $761000.0 in 2026.
• Business Quant data shows LMAT's Asset Writedowns and Impairment at $761000.0 in Q1 2026, $768000.0 in Q4 2025, and $863000.0 in Q3 2025.